CHAPTER XIII Treatment of pituitary dwarfism with human growth hormone
Paul Roos
Abstract
Paul Roos
Abstract
Summary Two mg HGH has been given twice a week to nine patients with pituitary dwarfism and to four children in whom pituitary dwarfism was suspected. All nine patients with proved hypopituitarism increased their growth velocity, the mean height increment during the first year of treatment being 10.5 cm. During the following years the growth velocity approached normal growth. None of the patients became resistant to the treatment and regular tests for antibodies were negative. None of four patients with doubtful hypopituitarism responded to the treatment.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Summary Two mg HGH has been given twice a week to nine patients with pituitary dwarfism and to four children in whom pituitary dwarfism was suspected. All nine patients with proved hypopituitarism increased their growth velocity, the mean height increment during the first year of treatment being 10.5 cm. During the following years the growth velocity approached normal growth. None of the patients became resistant to the treatment and regular tests for antibodies were negative. None of four patients with doubtful hypopituitarism responded to the treatment.
Key concepts: Dwarfism, Hypopituitarism, Medicine, Growth hormone, Growth velocity, Internal medicine, Endocrinology, Human growth hormone